ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells.

November 23, 2007

TCGA Researchers Discover Stomach Cancer Falls Into Four Distinct Molecular Subtypes

August 29, 2014

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991

Cancer Program Progress Detailed

March 5, 1976

CCOPs Payline Set In Low 220s Fr Now; 45 To Be Funded

May 15, 1987

ACCC To Present Program On Impact Of New Technology

January 23, 1981